Rapid Medical™ Completes Successful Ischemic Stroke Procedures with the World’s First Robotic Thrombectomy Device
May 14 2024 - 10:03AM
Business Wire
The procedures utilized an AI-powered, robotic TIGERTRIEVER
to automate and optimize personalized treatments
Rapid Medical™, a leading developer of advanced neurovascular
devices, announces the first successful robotic thrombectomy in
Medellín, Colombia. Two patients were treated with the Robotic
TIGERTRIEVER™, the first endovascular thrombectomy device that
adapts autonomously to the patient’s anatomy.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240514330734/en/
The AI-powered TIGERTRIEVER removes
stroke-causing blood clots during first-in-man procedures in
Colombia. Rapid Medical’s portfolio of active technology allows
greater procedural personalization, which is enhanced with AI
workflow. (Photo: Business Wire)
“Automating stroke procedures is a significant advancement for
the medical field,” emphasizes Dr. Boris Pabón, the endovascular
neurosurgeon at Angiosur who performed the first-in-man procedures.
“Robotic clot removal achieves a level of precision that surpasses
interventional capabilities. The robotic TIGERTRIEVER gives me
direct insight into the vessel characteristics and senses what I
cannot–truly remarkable.”
With the press of a button, the AI-activated TIGERTRIEVER
captures the blockage with active integration. The device’s radial
force is then automatically reduced to minimize trauma to the brain
as it is retrieved. This builds upon the excellent clinical results
and procedure times seen with TIGERTRIEVER’s adjustability, further
enhancing precision and streamlining workflow.
“Implementing this technology is a testament to our commitment
to expanding treatment for stroke patients worldwide,” affirms
Ronen Eckhouse, CEO of Rapid Medical. “We are at the forefront of
advancing care—first by providing physicians with active technology
and now paving a new pathway to automate procedures with
intelligent control.”
About Rapid Medical
Rapid Medical expands what’s possible in neurovascular treatment
by pioneering advanced interventional devices that treat ischemic
and hemorrhagic stroke. Utilizing proprietary manufacturing
techniques, Rapid Medical’s products are remotely adjustable and
fully visible. This enables physicians to respond in real time to
the anatomy and tailor the approach to every patient for better
procedural outcomes. TIGERTRIEVER™ 13, 17, and 21, COMANECI™ and
COLUMBUS™/DRIVEWIRE are CE marked and FDA cleared. TIGERTRIEVER XL
is also CE marked. More information is available at
www.rapid-medical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240514330734/en/
Ronen Eckhouse +972-72-2503331 ronen@rapid-medical.com